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Abstract: Sodium disorders are the most common and most poorly understood electrolyte dis-
orders in neurological patients. The aim of this study was to determine the incidence of sodium 
disorders and its association with different traumatic brain injuries. This prospective study was 
conducted in 80 patients diagnosed with moderate and severe traumatic brain injuries. All patients 
underwent cerebral computed tomography. Incidence of sodium disorders, presence of injuries 
in the first computed tomography after traumatic brain injury, and level of consciousness were 
  analyzed. Patients that presented other potential causes of sodium disorders and systemic trauma 
were excluded from the study. The incidence of sodium disturbances was 45%: 20 patients pre-
sented hypernatremia and 16 hyponatremia. Refers to all patients with sodium disturbances 53% 
were detected in the first sample. We recorded at least one measurement ,125 mEq/L in 50% of 
the patients with   hyponatremia. A greater incidence of sodium disorders was found in patients with 
subdural, intracerebral hematoma and with diffuse axonal injury. The incidence of sodium disorders 
among the patients with diffuse lesions was greater than in the group of patients with brain contusion 
(P = 0.022). The incidence of sodium disorders is higher in patients with diffuse traumatic brain 
injuries. No association was found between focal lesions and proportion of sodium disorders.
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Introduction
Serum sodium disorders are the most common and probably the most poorly   understood 
electrolyte disorders in neurological disease.1,2 The disturbance may manifest as hyper-
natremia or hyponatremia. Hypernatremia usually occurs in the syndrome of diabetes 
insipidus, whereas hyponatremia develops as a syndrome of inappropriate secretion of 
antidiuretic hormone or cerebral salt-wasting syndrome.2,3 It is well established that the 
outcomes of a traumatic brain injury (TBI) depend substantially on the   homeostasis 
disorders following the trauma. Hyponatremia is a common electrolyte disorder 
encountered in patients in the neurosurgical intensive care unit (ICU).1,4
The majority of recent studies that address the problem focus on the analysis of the 
neuroendocrinological mechanisms involved and therapeutic aspects.4 A few recent studies 
have been conducted on the prevalence, risk factors, associations with other conditions 
and parameters, and the results in the different types of cerebral illness. The majority of 
the studies that address these aspects deal with subarachnoid hemorrhage.5,6 Despite the 
importance of sodium disorders in TBI without systemic lesions in clinical practice, the 
incidence has been little studied. In this paper, the authors’ aim was to determine the preva-
lence of sodium disorders such as hypernatremia and hyponatremia and their association 
with TBI in stable patients in a university hospital with a level I trauma center.Therapeutics and Clinical Risk Management 2011:7 submit your manuscript | www.dovepress.com
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This study was approved by the ethical committee of 
Hospital Das Clinicas, University of São Paulo School of 
Medicine, São Paulo, Brazil.
Methods
This prospective study was conducted in 80 consecutive 
patients diagnosed with TBI who were managed in 1 year 
and were hospitalized in the surgical ICU of the authors’ 
hospital. All patients underwent neurosurgical examination, 
cervical spine and plain chest radiography, and cerebral 
computed tomography (CT). Patients underwent CT scans 
on two occasions: on hospital admission after resuscitation 
and within 12 hours after the first tomography. Hypertonic 
saline solution was not used in our cases, and no protocols 
with hypertonic saline solution for care in a rescue unit were 
adopted in Brazil. During this period, 2112 trauma patients 
were treated and, of these, 493 had moderate or severe TBI. 
Excluded from the study were those with prior sodium 
disorders or receiving diuretics (11 patients), 384 patients 
with associated systemic trauma (abdominal and orthopedic 
trauma; since these lesions often involve blood loss and 
need resuscitation with saline solution), and patients with 
moderate TBI not managed in the ICU (18 patients). After 
hospital admission with resuscitation by advanced trauma life 
support (ATLS) protocol, all patients with TBI and normal 
hemodynamic status were admitted to ICU and were included 
in this study. They did not receive diuretics and were free 
from renal or other endocrine diseases. Patients that presented 
other potential causes of sodium disorders and systemic 
trauma were excluded from the study. Sodium disorders were 
considered as disorders presenting at least one serum sodium 
  detection ,130 mEq/L or .145 mEq/L in the period from 
hospital admission (first sample collected in the emergency 
room during resuscitation) to 30 days (minimum follow-up) 
after TBI. In all patients, a standard blood sample was 
taken (collected directly from a peripheral vein in the arm 
or leg).
Patients who were hypo- or hypernatremic on admission, 
as well as those who developed sodium disorders during 
hospitalization, were included in the study. In patients with 
abnormal sodium, a blood sample was collected every day 
until correction of sodium and after that at least one blood 
sample per week during the first month after trauma.   Decisions 
regarding the management of sodium disorders were left to the 
physicians responsible and were not influenced by the study. 
For all measurements, an AVL 988-4 Electrolyte Analyzer 
(AVL Scientific Co, Roswell, GA) was used.
The characteristics of the patients analyzed were as 
  follows: incidence of sodium disorders, presence of injuries 
in the first CT scan of the skull after TBI (all scans were 
evaluated by two team members trained in CT evaluation), 
and level of consciousness according to the Glasgow 
coma scale (GCS).7 Only severe (GCS , 9) and moderate 
(GCS 9–13) TBI cases were considered in the study. The 
diagnostic criteria for diffuse injury was used in persistent 
comatose patients (more than 6 hours) and no focal lesions 
greater than 25 cm3 as described by Marshall et al.8 The 
great majority (81.3%) of the patients were male. The aver-
age age was 35 years, with substantial variation (3–87). 
A P value of less than 0.05 was considered significant. The 
statistical analyses were performed using SigmaStat® (Jadel 
Inc, Brandon, FL) software, applied within each subgroup 
analysis using chi-square test to compare proportions. The 
study protocol was approved by the ethics committee of 
the authors’ hospital.
Results
We recorded traumatic subarachnoid hemorrhage in 53% 
of the patients, 31% from acute subdural hematoma, 22% 
from acute epidural hematoma, and 7.5% with diffuse axonal 
injury with normal CT. We observed no ventricular hemor-
rhage. Of the 80 patients, 42 received surgical   treatment. 
The surgical treatments were as follows: 3 patients for 
intracranial pressure monitoring and 39 patients undergoing 
hematoma removal and/or evacuation of the contused brain. 
The prevalence of sodium disorders was 45%: 20 patients 
presented with hypernatremia and 16 with hyponatremia. 
Of these, 53% had already been detected in the first sample. 
In the early evolution of the condition, another 19 cases 
presented sodium disorders.   Hypernatremia, occurring in 
25% of the cases, was more prevalent than hyponatremia, 
as in the first sample (Table 1). The average time of the first 
detection was 5 days for hypernatremia and 6 days for the 
hyponatremia. In terms of severity, 17 patients presented 
at least one measurement .150 mEq (85% of the patients 
with hypernatremia findings). Of these, 5 (30%) occurred 
Table 1 Incidence of sodium disorders according to detec­
tion time
Detection time Hypernatremia Hyponatremia Total
First sample (in eR) 9 (11%) 8 (10%) 17 (21%)
Detection in ICU 11 (14%) 8 (10%) 19 (24%)
Total 20 (25%) 16 (20%) 36 (45%)
Abbreviations: eR, emergency room; ICU, intensive care unit.Therapeutics and Clinical Risk Management 2011:7 submit your manuscript | www.dovepress.com
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in the first blood analysis and 12 during the evolution. As 
an initial treatment, all 16 patients who presented with 
hyponatremia were given sodium supplementation therapy. 
However, 3 of these 16 patients (18.7%) presented recurrence 
of hyponatremia, which required sodium supplementation 
therapy again in the course of time. Sodium   excretion and 
pituitary hormone levels were not measured in these patients. 
At least one measurement ,125 mEq/L was found in eight 
patients (50% of the patients with hyponatremia findings), 
all occurring during the evolution. No differences between 
the incidences of disorders according to sex and age were 
observed. The patients with subdural, intracerebral hema-
toma and those with diffuse axonal injury had a greater 
incidence of sodium disorders, but these differences were not 
statistically significant (Table 2). The incidence of sodium 
disorders among the patients with diffuse lesions was greater 
than in the group of patients with intracerebral hematoma 
(P = 0.022) (Table 3).
Discussion
The incidence of sodium disorders was high in this study, 
and the results were similar to those of other series.9,10 The 
results of this study showed that a large number of patients 
presented sodium disorders after each type of TBI but no 
association with specific intracranial lesions was identi-
fied. The substantial rate of detection of disorders on the 
day of admission suggests severe brain lesions. Hyper-
natremia was the most frequent disorder in the authors’   
patients.
The mortality rates in head-injured patients with hyper-
natremia are higher than rates in such patients with normal 
sodium concentrations.11 Once the serum sodium concentra-
tion is elevated, it can result in remarkable brain   swelling. 
Since the amount of the infusion volume is controlled 
manually in head-injured patients, unexpected loss of free 
water as a result of excretion of hypotonic urine can induce 
hypernatremic dehydration. Furthermore, losses of water can 
decrease renal plasma flow and renal filtration rates, resulting 
in aggravation of the hypernatremia.11 Hyponatremia was 
detected in 20% of cases. Arieff et al found that the acute 
onset of severe hyponatremia following TBI was associated 
with a poor neurological outcome or death after a sudden 
onset of seizures, followed by coma, apnea, and brainstem 
compression.12
In a retrospective cohort study, Maggiore et al veri-
fied that hypernatremia was common, occurring in 51.5% 
of patients for 31% of the duration of their ICU stay.13 
  Hypernatremia was associated with a threefold increase in 
hazard of ICU death, even after adjustment for baseline risk. 
In the present study, the authors verified hypernatremia in 
25% of the patients; of these, 53% had already been detected 
in the first sample.
Horn and Glenn screened patients with severe head 
injury and found that 20% suffered from one or more 
hormone   disturbances.14 The cause of sodium disorders 
are diverse and the associated risk of morbidity vary 
widely. Therefore, early diagnosis and effective treatment 
of hyponatremia is critical for hyponatremic patients 
Table 2 Incidence of sodium disorders according to brain injury
Intracranial lesion and  
sodium disorders
Total N (%) Prevalence N (%) Odds ratio CI 95%
ASDH
No 55 (68.75) 24 (43.6) 1.0
Yes 25 (31.25) 12 (48.0) × 2: 0.13 p: 0.71 1.01 0.4–2.5
AEDH
No 62 (77.5) 28 (45.2) 1.0
Yes 18 (22.5) 8 (44.4) × 2: 0.004 p: 0.95 1.03 0.3–3.5
ICH
No 68 (85) 30 (44.1) 1.0
Yes 12 (15) 6 (50) × 2: 0.14 p: 0.7 0.8 0.3–3.5
TSAH
No 37 (46.2) 16 (43.2) 1.0
Yes 43 (53.7) 17 (39.2) × 2: 1.5 p: 0.2 0.6 0.2–1.4
DAI
No 74 (92.5) 42 (56.7) 1.0
Yes 6 (7.5) 4 (66.7) × 2: 0.35 p: 0.55 1.7 0.3–10
Abbreviations:  ASDh,  acute  subdural  hematoma;  AeDh,  acute  epidural  hematoma;  TSAh,  traumatic  subarachnoid  hemorrhage;  ICh,  intracerebral  hematoma;   
DAI, diffuse axonal lesion; CI, confidence interval; N, number.Therapeutics and Clinical Risk Management 2011:7 submit your manuscript | www.dovepress.com
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with intracranial disease. Neurological dysfunction is the 
principal manifestation of hyponatremia, which may be 
exacerbated by other disease processes or underlying condi-
tions, especially in those patients in whom a pathological 
condition is located intracranially.10 The high rate of serious 
alterations during the evolution suggests the possible occur-
rence of associated neuroendocrinological conditions such 
as diabetes insipidus, syndrome of inappropriate secretion 
of antidiuretic hormone, and cerebral salt wasting. The 
mechanism by which an intracranial disease leads to the 
occurrence of the syndrome has yet to be fully elucidated. 
There were no patients with diabetes insipidus in the present 
study. Because there was insufficient data on pituitary func-
tion and sodium excretion in patients, although syndrome 
of inappropriate antidiuretic hormone hypersecretion is the 
most common cause of hyponatremia,15 the cause of their 
hyponatremia remains unclear.
Hyponatremia may also be caused by the activity of 
the brain natriuretic factor (BNF), probably secreted by the 
thalamus, exerting an action identical to that of the hor-
mone secreted by the atrial cardiocytes.16,17 BNF is a potent 
diuretic, natriuretic, vasodilating agent, and an inhibitor of 
the secretion of aldosterone, renin, and vasopressin.18–20 It also 
decreases plasma volume. Increased BNF is most commonly 
found in patients with subarachnoid hemorrhage or hemor-
rhage at the base of the brain or in the third ventricle.21,22 
BNF was not measured in this study because the authors did 
not have the appropriate equipment. In the patients studied, 
there was no special pathological substrate to induce the 
effects of BNF, except for diffuse brain edema present in 
the majority of patients. The incidence of sodium disorders 
was high in study patients with diffuse TBI. No association 
was found between specific types of TBI and the proportion 
of sodium disorders, but the incidence of sodium disorders 
was greater in diffuse injury than in intracerebral hematoma. 
Disturbances of plasma sodium concentration warrant close 
attention in patients with craniocerebral injuries to allow 
timely and appropriate therapeutic intervention and prevent 
possible complications that may exacerbate conditions and 
eventually lead to death.
The authors believe that the selected sample allowed the 
exclusion of confounding variables to restrict head trauma 
without other injuries, but this deviated slightly from clini-
cal reality. The authors’ also believe that further studies with 
larger numbers of patients and blind comparison can respond 
to questions not answered in this study.
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